01 1Alembic Pharmaceuticals Limited
01 1DASATINIB
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2017-04-18
Pay. Date : 2017-03-27
DMF Number : 31282
Submission : 2017-03-31
Status : Active
Type : II
20
Alembic Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is DASATINIB, with a corresponding US DMF Number 31282.
Remarkably, this DMF maintains an Active status since its submission on March 31, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 18, 2017, and payment made on March 27, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II
LOOKING FOR A SUPPLIER?